1
On Wednesday, a federal court issued a nationwide preliminary injunction against the National Institutes of Health (NIH) following its abrupt decision to slash and cap indirect cost rates on biomedical research grants.
The ruling prevents implementing the policy change, which would affect billions of dollars in funding and disrupt ongoing research and clinical trials.
The controversy began when NIH released a Supplemental Guidance on February 7, 2025, modifying indirect cost rates in grant awards.
NIH said it would now apply a standard indirect cost rate of 15% to all new and existing grants, replacing …
